Cas 205494-27-5,(3S,4R)-3-{N-benzyloxycarbonyl-β-(2-naphthyl)-L-alanyl}-amino-4-{3-(morpholin-4-yl)-phenoxy}-azetidin-2-one

205494-27-5

Post Buying Request

Basic information

Product Name: (3S,4R)-3-{N-benzyloxycarbonyl-β-(2-naphthyl)-L-alanyl}-amino-4-{3-(morpholin-4-yl)-phenoxy}-azetidin-2-one
Synonyms:
CAS NO:205494-27-5
Molecular Formula:
Molecular Weight: 594.667
EINECS: N/A
Product Categories: N/A
Mol File: 205494-27-5.mol
Article Data: 2

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: (3S,4R)-3-{N-benzyloxycarbonyl-β-(2-naphthyl)-L-alanyl}-amino-4-{3-(morpholin-4-yl)-phenoxy}-azetidin-2-one(CAS DataBase Reference)
NIST Chemistry Reference: (3S,4R)-3-{N-benzyloxycarbonyl-β-(2-naphthyl)-L-alanyl}-amino-4-{3-(morpholin-4-yl)-phenoxy}-azetidin-2-one(205494-27-5)
EPA Substance Registry System: (3S,4R)-3-{N-benzyloxycarbonyl-β-(2-naphthyl)-L-alanyl}-amino-4-{3-(morpholin-4-yl)-phenoxy}-azetidin-2-one(205494-27-5)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 205494-27-5(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

205494-27-5 Suppliers

Recommended suppliersmore

205494-27-5 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 205494-27-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,5,4,9 and 4 respectively; the second part has 2 digits, 2 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 205494-27:
(8*2)+(7*0)+(6*5)+(5*4)+(4*9)+(3*4)+(2*2)+(1*7)=125
125 % 10 = 5
So 205494-27-5 is a valid CAS Registry Number.

205494-27-5Upstream product

205494-27-5Downstream Products

205494-27-5Relevant articles and documents

3,4-DISUBSTITUTED AZETIDIN-2-ONE DERIVATIVES USEFUL AS CYSTEINE PROTEINASE REGULATORS

-

, (2008/06/13)

The present invention is based on the discovery that certain 3,4-disubstituted-azetidin-2-one derivatives exhibit excellent cysteine proteinase inhibitory activity which can be used for treatment of different diseases such as muscular dystrophy, myocardia

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 205494-27-5